Transforming Growth Factor-β–Activated Kinase 1 Impedes Peripheral Nerve Regeneration after Injury by Evoking Sustained Inflammation
The American Journal of Pathology · 2026-09
DOI: 10.1016/j.ajpath.2026.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-09. Verfasst von Xiaoyu Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Cente…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Peripheral nerve injury often leads to severe functional deficits, yet the molecular mechanisms underlying nerve regeneration remain incompletely understood. Here, the function of transforming growth factor-β-activated kinase 1 (TAK1) in peripheral nerve regeneration was examined using murine and rat models of sciatic nerve injury. The results show that TAK1 overexpression impairs nerve regeneration and functional recovery, whereas pharmacologic inhibition of TAK1 with takinib promotes these processes. Mechanistically, the detrimental effects of TAK1 are associated with sustained inflammatory responses within the sciatic nerve. TAK1 is predominantly expressed in Schwann cells and fibroblasts in the sciatic nerve, where it activates NF-κB signaling. Specifically, TAK1 phosphorylates protein phosphatase 1 regulatory subunit 18 at serine 213, thereby relieving its suppression on the NF-κB pathway and facilitating the nuclear accumulation of NF-κB p65. This activation drives chemokine expression, leading to enhanced recruitment of M1 macrophages and the establishment of a proinflammatory microenvironment that impedes remyelination and nerve regeneration. Collectively, these findings identify TAK1 as a critical negative regulator of peripheral nerve repair and highlight TAK1 inhibition as a potential therapeutic approach for improving recovery following peripheral nerve injury.
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China.
- Department of Emergency Medicine, Affiliated Hospital of Nantong University, Nantong, China. Electronic address: cyu1299@126.com.
- Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China. Electronic…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Zhang, S., Wu, Z., Zhang, M., Ju, Q., Tang, X., Chen, Y., & Sun, C. (2026). Transforming Growth Factor-β–Activated Kinase 1 Impedes Peripheral Nerve Regeneration after Injury by Evoking Sustained Inflammation. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2026.09.001
Vancouver
Liu X, Zhang S, Wu Z, Zhang M, Ju Q, Tang X, et al. Transforming Growth Factor-β–Activated Kinase 1 Impedes Peripheral Nerve Regeneration after Injury by Evoking Sustained Inflammation. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2026.09.001
BibTeX
@article{Liu2026,
author = {Liu, Xiaoyu and Zhang, Shouping and Wu, Zhiguan and Zhang, Meichen and Ju, Qianqian and Tang, Xin and Chen, Yu and Sun, Cheng},
title = {Transforming Growth Factor-β–Activated Kinase 1 Impedes Peripheral Nerve Regeneration after Injury by Evoking Sustained Inflammation},
journal = {The American Journal of Pathology},
year = {2026},
doi = {10.1016/j.ajpath.2026.09.001}
}
EUVIMED